Event
TechBio UK 2025
October 16
TechBio UK brings together companies working at the interface of biotechnology and technology to network, learn and showcase new advances in the biotech industry.
CC experts will be on hand to share insights from our position at the cutting-edge of deep tech. We bring a unique perspective by leveraging our experience across multidisciplinary technologies to help clients navigate the end-to-end journey from ambition to commercial impact.
Vishal Sanchania, Commercial Director will be taking part in a discussion around new ways of generating and interpreting data. He’ll be sharing insights based on his experience of leading cutting edge biotechnology research across pharmaceutical, high value molecules, biocatalysis, automation, synthetic biology and AI disciplines.
Panel session – Therapeutics & Discovery Track: New ways of generating and interpreting data
Panel session overview:
New foundational models for therapeutic applications are increasingly available, and are being embraced by some regulatory bodies. Join us as we discuss how companies can best deploy these, as well as other new ways to generate data to demonstrate efficacy
時間： 3:15pm – 4:00pm
Speakers:
- Jenny Barnett – Co-Founder, Chief Executive Officer, Monument Tx
- Emma Lawrence – Senior Policy and Public Affairs Manager, BIA
- Agata Nyga – CEO and Founder, SynLaia Innovations
- David Powell – President, Drug Discovery , Relation Therapeutics
- Vishal Sanchania – Commercial Director, Cambridge Consultants
Going to BioTech UK? Connect with us
Vishal Sanchania is Commercial Director at Cambridge Consultants. He currently specialises in helping clients realise the potential of converging the physical sciences and AI with biology.